Paloma Partners’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,663
Closed -$260K 2300
2021
Q1
$260K Sell
2,663
-432
-14% -$39.3K 0.01% 1598
2020
Q4
$238K Sell
3,095
-4,328
-58% -$335K 0.01% 1295
2020
Q3
$547K Sell
7,423
-11,805
-61% -$947K 0.01% 1102
2020
Q2
$1.41M Buy
+19,228
New +$1.51M 0.02% 767
2020
Q1
Sell
-3,176
Closed -$249K 2101
2019
Q4
$249K Sell
3,176
-2,940
-48% -$217K ﹤0.01% 1865
2019
Q3
$419K Buy
6,116
+2,470
+68% +$166K 0.01% 1292
2019
Q2
$290K Sell
3,646
-2,895
-44% -$230K ﹤0.01% 1321
2019
Q1
$549K Buy
6,541
+4,774
+270% +$498K 0.01% 1012
2018
Q4
$208K Sell
1,767
-2,400
-58% -$278K 0.01% 1041
2018
Q3
$502K Buy
4,167
+245
+6% +$30.4K 0.01% 1028
2018
Q2
$452K Buy
+3,922
New +$429K 0.01% 1078
2016
Q2
Sell
-6,630
Closed -$403K 2354
2016
Q1
$403K Sell
6,630
-3,140
-32% -$185K 0.01% 1411
2015
Q4
$624K Buy
9,770
+6,570
+205% +$426K 0.02% 904
2015
Q3
$215K Buy
+3,200
New +$226K 0.01% 1441
2015
Q1
Sell
-4,150
Closed -$213K 1438
2014
Q4
$213K Buy
+4,150
New +$204K 0.01% 984

Other funds holding USNA

Paloma Partners's USNA Position: Q2 2021 in Review

Paloma Partners sold out of Usana Health Sciences (USNA) in Q2 2021, closing a stake of 2,663 shares — an estimated $260K sold.

Paloma Partners first reported a position in USNA in Q4 2014 and held it in 15 quarters. The position peaked at $1.41M in Q2 2020. 188 funds tracked by Wall St. Rank hold USNA as of Q2 2021.

  • Paloma Partners reported no remaining Usana Health Sciences position as of Q2 2021 after selling out during the quarter.
  • Paloma Partners sold 2,663 Usana Health Sciences shares in Q2 2021, an estimated $260K.
  • Paloma Partners first reported a position in Usana Health Sciences in Q4 2014 and held it in 15 quarters.
  • Paloma Partners's Usana Health Sciences position peaked at $1.41M in Q2 2020.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.